Literature DB >> 26463994

Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer.

Li-rong Ren1, Li-ping Zhang1, Shu-ying Huang2, Yuan-fang Zhu3,4, Wen-juan Li2, Shan-yu Fang2, Li Shen2, Yan-ling Gao2.   

Abstract

Ovarian cancer is one of the most common malignancies encountered in the world. In ovarian cancer tissues of patients, NEU1 was expressed in a higher level than that in adjacent normal tissues. In this research, we aimed to elucidate the role of NEU1 siRNA on proliferation, apoptosis, and invasion of OVCAR3 and SKOV3 cells which expressed NEU1 notably. By cell viability assay and flow cytometry method, we found that NEU1 siRNA effectively inhibited the cancer proliferation, arrested cells cycle at G0/G1 phase, and induced apoptosis when compared to the Mock group. Result of transwell assay showed that invasion of cells in OVCAR3 and SKOV3 treated with NEU1 siRNA were suppressed significantly. Gene set enrichment analysis showed that lysosome and oxidative phosphorylation related signal pathway were associated with the NEU1 expression. In addition, Western blot revealed that expressions of Cln3 and Cln5 were depressed, and ATP5B and ATP5J expressions were also reduced. In conclusion, NEU1 siRNA can effectively inhibit proliferation, apoptosis, and invasion of human ovarian cancer cells by targeting lysosome and oxidative phosphorylation signaling, which can serve as a new target ovarian cancer treatment.

Entities:  

Keywords:  Apoptosis; Invasion; NEU1; Ovarian cancer; Proliferation

Mesh:

Substances:

Year:  2015        PMID: 26463994     DOI: 10.1007/s11010-015-2583-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Porcine skeletal muscle differentially expressed gene ATP5B: molecular characterization, expression patterns, and association analysis with meat quality traits.

Authors:  Haixia Xu; Yongjie Xu; Xiaojuan Liang; Yanbo Wang; Fangfang Jin; Dengying Liu; Yun Ma; Hongyu Yuan; Xinqiang Song; Wenxian Zeng
Journal:  Mamm Genome       Date:  2013-02-19       Impact factor: 2.957

2.  Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma.

Authors:  Henriette Bjerregaard; Shona Pedersen; Søren Risom Kristensen; Niels Marcussen
Journal:  Diagn Mol Pathol       Date:  2011-12

3.  Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.

Authors:  E Bonten; A van der Spoel; M Fornerod; G Grosveld; A d'Azzo
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

4.  Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs).

Authors:  Weiwei Yang; Yan Lu; Yichen Xu; Lizhi Xu; Wei Zheng; Yuanyuan Wu; Long Li; Pingping Shen
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

5.  ATP synthase from bovine heart mitochondria. In vitro assembly of a stalk complex in the presence of F1-ATPase and in its absence.

Authors:  I R Collinson; M J van Raaij; M J Runswick; I M Fearnley; J M Skehel; G L Orriss; B Miroux; J E Walker
Journal:  J Mol Biol       Date:  1994-09-30       Impact factor: 5.469

6.  GSEA-P: a desktop application for Gene Set Enrichment Analysis.

Authors:  Aravind Subramanian; Heidi Kuehn; Joshua Gould; Pablo Tamayo; Jill P Mesirov
Journal:  Bioinformatics       Date:  2007-07-20       Impact factor: 6.937

Review 7.  Oncogenes in ovarian cancer.

Authors:  A Berchuck; M F Kohler; R C Bast
Journal:  Hematol Oncol Clin North Am       Date:  1992-08       Impact factor: 3.722

8.  Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.

Authors:  Susan Pattison; Michael Pankarican; C Anthony Rupar; Frank L Graham; Suleiman A Igdoura
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

9.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.

Authors:  Elisabet Hjerpe; Suzanne Egyhazi Brage; Joseph Carlson; Marianne Frostvik Stolt; Kjell Schedvins; Hemming Johansson; Maria Shoshan; Elisabeth Avall-Lundqvist
Journal:  BMC Clin Pathol       Date:  2013-11-19
View more
  13 in total

1.  Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells.

Authors:  Padmamalini Thulasiraman; Kelbie Kerr; Kathleen McAlister; Samantha Hardisty; Albany Wistner; Ian McCullough
Journal:  Mol Cell Biochem       Date:  2019-09-12       Impact factor: 3.396

2.  Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma.

Authors:  Harvind S Chahal; Wenting Wu; Katherine J Ransohoff; Lingyao Yang; Haley Hedlin; Manisha Desai; Yuan Lin; Hong-Ji Dai; Abrar A Qureshi; Wen-Qing Li; Peter Kraft; David A Hinds; Jean Y Tang; Jiali Han; Kavita Y Sarin
Journal:  Nat Commun       Date:  2016-08-19       Impact factor: 14.919

3.  Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma.

Authors:  Guojun Hou; Gang Liu; Yuan Yang; Yixue Li; Shengxian Yuan; Linghao Zhao; Mengchao Wu; Lei Liu; Weiping Zhou
Journal:  Oncotarget       Date:  2016-10-04

4.  Metastatic cancer cell attachment to endothelium is promoted by endothelial glycocalyx sialic acid degradation.

Authors:  Solomon A Mensah; Ian C Harding; Michelle Zhang; Michael P Jaeggli; Vladimir P Torchilin; Mark J Niedre; Eno E Ebong
Journal:  AIChE J       Date:  2019-05-09       Impact factor: 3.993

5.  Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.

Authors:  Xiaoman Zhou; Yanhong Zhai; Changmei Liu; Ganglong Yang; Jia Guo; Guang Li; Chengwen Sun; Xiaowei Qi; Xiang Li; Feng Guan
Journal:  Cell Commun Signal       Date:  2020-03-12       Impact factor: 5.712

Review 6.  Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?

Authors:  Camille Albrecht; Aline Appert-Collin; Dominique Bagnard; Sébastien Blaise; Béatrice Romier-Crouzet; Roman G Efremov; Hervé Sartelet; Laurent Duca; Pascal Maurice; Amar Bennasroune
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

7.  Identification and Evaluation of New Potential Inhibitors of Human Neuraminidase 1 Extracted from Olyra latifolia L.: A Preliminary Study.

Authors:  Camille Albrecht; Zachée Louis Evariste Akissi; Philomène Akoua Yao-Kouassi; Abdulmagid Alabdul Magid; Pascal Maurice; Laurent Duca; Laurence Voutquenne-Nazabadioko; Amar Bennasroune
Journal:  Biomedicines       Date:  2021-04-11

8.  Inhibitors of Human Neuraminidase Enzymes Block Transmigration in vitro.

Authors:  Md Amran Howlader; Tianlin Guo; Christopher W Cairo
Journal:  Front Mol Biosci       Date:  2022-02-25

9.  Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.

Authors:  Enrique de Álava; Lourdes Hontecillas-Prieto; Daniel J García-Domínguez; Nabil Hajji; Roser López-Alemany; Sara Sánchez-Molina; Elisabet Figuerola-Bou; Francisco J Morón Civanto; Santiago Rello-Varona; Eduardo Andrés-León; Adrián Benito; Hector C Keun; Jaume Mora; Óscar M Tirado
Journal:  Oncogene       Date:  2022-03-30       Impact factor: 8.756

Review 10.  The CLN3 gene and protein: What we know.

Authors:  Myriam Mirza; Anna Vainshtein; Alberto DiRonza; Uma Chandrachud; Luke J Haslett; Michela Palmieri; Stephan Storch; Janos Groh; Niv Dobzinski; Gennaro Napolitano; Carolin Schmidtke; Danielle M Kerkovich
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.